 MORRISVILLE, N.C., Nov. 02, 2020 GLOBE NEWSWIRE -- Syneos Health Nasdaq:SYNH, the only fully integrated biopharmaceutical solutions organization combining a CRO Contract Research Organization and a CCO Contract Commercial Organization, today announced that management is scheduled to present at two upcoming investor conferences: 